• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的胶质母细胞瘤术前生长动力学:指数生长类型的描述、相关因素及其与术后生存的关联。

Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival.

作者信息

Feucht Daniel, Haas Patrick, Skardelly Marco, Behling Felix, Rieger David, Bombach Paula, Paulsen Frank, Hoffmann Elgin, Hauser Till-Karsten, Bender Benjamin, Renovanz Mirjam, Niyazi Maximilian, Tabatabai Ghazaleh, Tatagiba Marcos, Roder Constantin

机构信息

Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany.

Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.

出版信息

Neurooncol Adv. 2024 Apr 3;6(1):vdae053. doi: 10.1093/noajnl/vdae053. eCollection 2024 Jan-Dec.

DOI:10.1093/noajnl/vdae053
PMID:38680987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11046984/
Abstract

BACKGROUND

Little is known about the growth dynamics of untreated glioblastoma and its possible influence on postoperative survival. Our aim was to analyze a possible association of preoperative growth dynamics with postoperative survival.

METHODS

We performed a retrospective analysis of all adult patients surgically treated for newly diagnosed glioblastoma at our center between 2010 and 2020. By volumetric analysis of data of patients with availability of ≥3 preoperative sequential MRI, a growth pattern was aimed to be identified. Main inclusion criterion for further analysis was the availability of two preoperative MRI scans with a slice thickness of 1 mm, at least 7 days apart. Individual growth rates were calculated. Association with overall survival (OS) was examined by multivariable.

RESULTS

Out of 749 patients screened, 13 had ≥3 preoperative MRI, 70 had 2 MRI and met the inclusion criteria. A curve estimation regression model showed the best fit for exponential tumor growth. Median tumor volume doubling time (VDT) was 31 days, median specific growth rate (SGR) was 2.2% growth per day. SGR showed negative correlation with tumor size (rho = -0.59,  < .001). Growth rates were dichotomized according to the median SGR.OS was significantly longer in the group with slow growth (log-rank:  = .010). Slower preoperative growth was independently associated with longer overall survival in a multivariable Cox regression model for patients after tumor resection.

CONCLUSIONS

Especially small lesions suggestive of glioblastoma showed exponential tumor growth with variable growth rates and a median VDT of 31 days. SGR was significantly associated with OS in patients with tumor resection in our sample.

摘要

背景

关于未经治疗的胶质母细胞瘤的生长动力学及其对术后生存的可能影响,人们了解甚少。我们的目的是分析术前生长动力学与术后生存之间的可能关联。

方法

我们对2010年至2020年间在本中心接受手术治疗的所有新诊断胶质母细胞瘤成年患者进行了回顾性分析。通过对有≥3次术前连续MRI数据的患者进行体积分析,旨在确定生长模式。进一步分析的主要纳入标准是有两次术前MRI扫描,层厚1毫米,间隔至少7天。计算个体生长率。通过多变量分析检查与总生存期(OS)的关联。

结果

在筛查的749例患者中,13例有≥3次术前MRI,70例有2次MRI且符合纳入标准。曲线估计回归模型显示最适合指数型肿瘤生长。中位肿瘤体积倍增时间(VDT)为31天,中位比生长率(SGR)为每天2.2%的生长率。SGR与肿瘤大小呈负相关(rho = -0.59,P <.001)。根据中位SGR将生长率进行二分法划分。生长缓慢组的OS明显更长(对数秩检验:P =.010)。在肿瘤切除术后患者的多变量Cox回归模型中,术前生长较慢与更长的总生存期独立相关。

结论

尤其是提示为胶质母细胞瘤的小病灶显示出指数型肿瘤生长,生长率各异,中位VDT为31天。在我们的样本中,SGR与肿瘤切除患者的OS显著相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f1/11046984/3bc5b7cc1a3b/vdae053_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f1/11046984/23f8c854855f/vdae053_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f1/11046984/16f89fb3e19c/vdae053_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f1/11046984/3bc5b7cc1a3b/vdae053_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f1/11046984/23f8c854855f/vdae053_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f1/11046984/16f89fb3e19c/vdae053_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99f1/11046984/3bc5b7cc1a3b/vdae053_fig3.jpg

相似文献

1
Preoperative growth dynamics of untreated glioblastoma: Description of an exponential growth type, correlating factors, and association with postoperative survival.未经治疗的胶质母细胞瘤术前生长动力学:指数生长类型的描述、相关因素及其与术后生存的关联。
Neurooncol Adv. 2024 Apr 3;6(1):vdae053. doi: 10.1093/noajnl/vdae053. eCollection 2024 Jan-Dec.
2
Impact of removed tumor volume and location on patient outcome in glioblastoma.切除肿瘤体积和位置对胶质母细胞瘤患者预后的影响。
J Neurooncol. 2017 Oct;135(1):161-171. doi: 10.1007/s11060-017-2562-1. Epub 2017 Jul 6.
3
Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.多形性胶质母细胞瘤患者同步放化疗后辅助替莫唑胺治疗的长期随访结果。MRI信息对生存的重要性:单中心经验。
Ideggyogy Sz. 2018 Mar 30;71(3-04):95-103. doi: 10.18071/isz.71.0095.
4
Glioblastoma survival is better analyzed on preradiotherapy MRI than on postoperative MRI residual volumes: A retrospective observational study.术前磁共振成像比术后磁共振成像残余体积更能分析胶质母细胞瘤的生存情况:一项回顾性观察研究。
Clin Neurol Neurosurg. 2020 Sep;196:105972. doi: 10.1016/j.clineuro.2020.105972. Epub 2020 May 29.
5
Volume Doubling Times of Pulmonary Metastases in Patients With Bone and Soft-Tissue Sarcomas: Associations With Subsequent New Metastases and Survival After Metastasectomy.骨肉瘤和软组织肉瘤患者肺转移瘤的体积倍增时间:与后续新转移灶及转移瘤切除术后生存率的相关性
AJR Am J Roentgenol. 2022 Apr;218(4):624-632. doi: 10.2214/AJR.21.26859. Epub 2021 Nov 3.
6
Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma.未经治疗的术前人类胶质母细胞瘤的对比增强肿瘤生长动力学
Cancer. 2016 Jun 1;122(11):1718-27. doi: 10.1002/cncr.29957. Epub 2016 Mar 21.
7
Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.最大程度切除增强和非增强肿瘤与新诊断胶质母细胞瘤患者分子亚群生存的关联。
JAMA Oncol. 2020 Apr 1;6(4):495-503. doi: 10.1001/jamaoncol.2019.6143.
8
Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.胶质母细胞瘤中液体衰减反转恢复序列(FLAIR)体积变化的动态变化及生存预测
Ann Surg Oncol. 2017 Mar;24(3):794-800. doi: 10.1245/s10434-016-5635-z. Epub 2016 Oct 20.
9
Breast Cancer Growth on Serial MRI: Volume Doubling Time Based on 3-Dimensional Tumor Volume Assessment.基于三维肿瘤体积评估的乳腺癌 MRI 连续生长:体积倍增时间。
J Magn Reson Imaging. 2023 Oct;58(4):1303-1313. doi: 10.1002/jmri.28670. Epub 2023 Mar 6.
10
Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.替莫唑胺长期治疗是新诊断胶质母细胞瘤的一种可行选择:一家机构多达101个替莫唑胺疗程的经验。
Neurosurg Focus. 2014 Dec;37(6):E4. doi: 10.3171/2014.9.FOCUS14502.

引用本文的文献

1
Establishment and validation of a nomogram for predicting IDH-wildtype glioblastomas in nonenhancing adult-type diffuse gliomas.预测非强化型成人型弥漫性胶质瘤中异柠檬酸脱氢酶野生型胶质母细胞瘤的列线图的建立与验证
Neurooncol Adv. 2025 Feb 8;7(1):vdaf035. doi: 10.1093/noajnl/vdaf035. eCollection 2025 Jan-Dec.
2
Agent-based modeling of cellular dynamics in adoptive cell therapy.过继性细胞治疗中基于主体的细胞动力学建模
bioRxiv. 2025 Feb 21:2025.02.17.638701. doi: 10.1101/2025.02.17.638701.

本文引用的文献

1
Does waiting for surgery matter? How time from diagnostic MRI to resection affects outcomes in newly diagnosed glioblastoma.等待手术是否重要?新诊断的胶质母细胞瘤从诊断性 MRI 到切除的时间如何影响结果。
J Neurosurg. 2023 Jun 23;140(1):80-93. doi: 10.3171/2023.5.JNS23388. Print 2024 Jan 1.
2
Intraoperative MRI-Guided Resection Is Not Superior to 5-Aminolevulinic Acid Guidance in Newly Diagnosed Glioblastoma: A Prospective Controlled Multicenter Clinical Trial.术中磁共振引导切除并不优于 5-氨基酮戊酸引导在新诊断的胶质母细胞瘤:一项前瞻性对照多中心临床试验。
J Clin Oncol. 2023 Dec 20;41(36):5512-5523. doi: 10.1200/JCO.22.01862. Epub 2023 Jun 19.
3
Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma.
RCAS-tva诱导的血小板衍生生长因子B驱动的实验性胶质瘤的多参数纵向分析
Brain Sci. 2022 Oct 24;12(11):1426. doi: 10.3390/brainsci12111426.
4
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.美国 2014-2018 年诊断的原发性脑和其他中枢神经系统肿瘤 CBTRUS 统计报告。
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105. doi: 10.1093/neuonc/noab200.
5
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
6
The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery.层厚对立体定向放射外科治疗脑转移瘤轮廓的影响
Adv Radiat Oncol. 2021 Apr 11;6(4):100708. doi: 10.1016/j.adro.2021.100708. eCollection 2021 Jul-Aug.
7
Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study.胶质母细胞瘤手术时机与患者预后:一项多中心队列研究
Neurooncol Adv. 2021 Apr 8;3(1):vdab053. doi: 10.1093/noajnl/vdab053. eCollection 2021 Jan-Dec.
8
Evidence-based recommendations on categories for extent of resection in diffuse glioma.弥漫性胶质瘤切除范围分类的循证医学建议。
Eur J Cancer. 2021 May;149:23-33. doi: 10.1016/j.ejca.2021.03.002. Epub 2021 Apr 2.
9
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.EANO 成人弥漫性胶质瘤诊断与治疗指南。
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8.
10
Association of tumor growth rates with molecular biomarker status: a longitudinal study of high-grade glioma.肿瘤生长速率与分子生物标志物状态的相关性:一项高级别胶质瘤的纵向研究。
Aging (Albany NY). 2020 May 9;12(9):7908-7926. doi: 10.18632/aging.103110.